{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:35:01Z","timestamp":1781307301021,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ekir.2022.12.009","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T12:25:04Z","timestamp":1671884704000},"page":"619-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series"],"prefix":"10.1016","volume":"8","author":[{"given":"Aishwarya","family":"Ravindran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Monteiro","family":"Pereira Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9952-209X","authenticated-orcid":false,"given":"Fernando C.","family":"Fervenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-7709","authenticated-orcid":false,"given":"Sanjeev","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2022.12.009_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.12.009_bib2","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3389\/fimmu.2017.01800","article-title":"Functional characterization of the disease-associated N-terminal complement factor H mutation W198R","volume":"8","author":"Cserhalmi","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2022.12.009_bib3","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1681\/ASN.2015020184","article-title":"Kidney disease caused by dysregulation of the complement alternative pathway: an etiologic approach","volume":"26","author":"De Vriese","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.12.009_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.ajkd.2014.06.035","article-title":"Complement in kidney disease: core curriculum 2015","volume":"65","author":"Thurman","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2022.12.009_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2022.12.009_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00467-021-05370-8","article-title":"Thrombotic microangiopathy in children","volume":"37","author":"Palma","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2022.12.009_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.imlet.2014.01.014","article-title":"Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome","volume":"160","author":"J\u00f3zsi","year":"2014","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ekir.2022.12.009_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.kint.2017.10.022","article-title":"C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy","volume":"93","author":"Bomback","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.12.009_bib9","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.mayocp.2016.05.015","article-title":"Thrombotic microangiopathy care pathway: a consensus statement for the Mayo Clinic complement alternative pathway-thrombotic microangiopathy (CAP-TMA) disease-oriented group","volume":"91","author":"Go","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ekir.2022.12.009_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.mayocp.2018.05.019","article-title":"C3 glomerulopathy: ten years\u2019 experience at Mayo Clinic","volume":"93","author":"Ravindran","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ekir.2022.12.009_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.12.009_bib12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.12.009_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ndt\/gfw290","article-title":"Characterization of C3 in C3 glomerulopathy","volume":"32","author":"Sethi","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2022.12.009_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.12.009_bib15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0034-1375701","article-title":"Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS)","volume":"40","author":"Sethi","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ekir.2022.12.009_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.kint.2018.01.037","article-title":"C3 glomerulopathy associated with monoclonal Ig is a distinct subtype","volume":"94","author":"Ravindran","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.12.009_bib18","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1002\/ajh.25551","article-title":"Biopsy-proven thrombotic microangiopathy without schistocytosis on peripheral blood smear: a cautionary tale","volume":"94","author":"Murphree","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ekir.2022.12.009_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ki.2012.384","article-title":"Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement","volume":"83","author":"Sethi","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.12.009_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/831834","article-title":"Kidney and urinary tract involvement in Kawasaki disease","volume":"2013","author":"Watanabe","year":"2013","journal-title":"Int J Pediatr"},{"key":"10.1016\/j.ekir.2022.12.009_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.kint.2017.07.015","article-title":"Complete functional characterization of disease-associated genetic variants in the complement factor H gene","volume":"93","author":"Merinero","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.12.009_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ekir.2022.12.009_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.12.009_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","article-title":"Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals","volume":"151","author":"Pickering","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ekir.2022.12.009_bib25","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1681\/ASN.2015030295","article-title":"Partial complement factor H deficiency associates with C3 glomerulopathy and thrombotic microangiopathy","volume":"27","author":"Vernon","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.12.009_bib26","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1073\/pnas.1219260110","article-title":"Dimerization of complement factor H-related proteins modulates complement activation in\u00a0vivo","volume":"110","author":"Goicoechea de Jorge","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2022.12.009_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-6143.2010.03333.x","article-title":"Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant","volume":"11","author":"Vernon","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2022.12.009_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/13816810.2015.1101777","article-title":"Retinal disease in the C3 glomerulopathies and the risk of impaired vision","volume":"37","author":"Savige","year":"2016","journal-title":"Ophthal Genet"},{"key":"10.1016\/j.ekir.2022.12.009_bib29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","article-title":"Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis","volume":"376","author":"Gale","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2022.12.009_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1242\/dmm.008052","article-title":"Regulating complement in the kidney: insights from CFHR5 nephropathy","volume":"4","author":"Gale","year":"2011","journal-title":"Dis Model Mech"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922019052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922019052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:42:34Z","timestamp":1762832554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024922019052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2468024922019052"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2022.12.009","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2022.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}